Botulinum toxin in fracture management: a scoping review
European Journal of Orthopaedic Surgery & Traumatology · 2025
DOI: 10.1007/s00590-025-04295-4 ↗Kurz gefasst
Scoping Review in der Zeitschrift European Journal of Orthopaedic Surgery & Traumatology, 2025. Verfasst von Emmanuel Spanoudakis und 7 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom. e.span98@yahoo.com. Hauptthemen laut MEDLINE: Botulinum Toxins, Fracture Healing, Fractures, Bone, Neuromuscular Agents. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Aristotle University of Thessaloniki.
Abstract (Originalsprache)
Purpose
Using botulinum toxin (BoNT) as an adjunct in fracture management is a novel approach with the potential to improve clinical outcomes, particularly in atypical fractures and patients with concurrent neuromuscular disorders. This scoping review explores the literature on BoNT’s effectiveness in facilitating fracture healing and immobilisation across various fracture types.
Methods
The PubMed, Embase, and Cochrane databases were searched with defined operators. Two investigators conducted independent searches, which were combined. Animal studies, case reports, case series, cohort reviews and randomised control trials were included.
Results
Fifty studies were identified for screening, from which 15 studies were included in the review. The findings highlight mixed outcomes in BoNT’s role in enhancing bone healing and reducing muscle-induced displacement. While BoNT injections demonstrated potential benefits in specific cases, such as atypical fractures, periprosthetic fractures and fractures in patients with motor dysfunctions, results from animal studies were inconsistent, showing varied effects on callous formation and bone mineral density.
Conclusion
Clinical applications of BoNT in fracture management indicate its utility as an immobilisation agent to promote fracture healing and reduce complications. However, this review highlights that further research is necessary to bridge the gap between experimental and clinical studies and to clarify BoNT’s effectiveness in different use cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom. e.span98@yahoo.com.
- Aristotle University of Thessaloniki, Thessaloniki, Greece. themisvamper@yahoo.com.
- University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
- Surrey and Borders Partnership NHS Foundation Trust, Leatherhead, United Kingdom.
- Aristotle University of Thessaloniki, Thessaloniki, Greece.
- Papageorgiou General Hospital, Thessaloniki, Greece.
Förderung
- Aristotle University of Thessaloniki
Zitieren
APA
Spanoudakis, E., Vampertzis, T., Wadia, F., Rad, D. R., Barmpagianni, C., Zervos, I. A., Tsiridis, E., & Galanis, N. (2025). Botulinum toxin in fracture management: a scoping review. European Journal of Orthopaedic Surgery & Traumatology. https://doi.org/10.1007/s00590-025-04295-4
Vancouver
Spanoudakis E, Vampertzis T, Wadia F, Rad DR, Barmpagianni C, Zervos IA, et al. Botulinum toxin in fracture management: a scoping review. European Journal of Orthopaedic Surgery & Traumatology. 2025. doi:10.1007/s00590-025-04295-4
BibTeX
@article{Spanoudakis2025,
author = {Spanoudakis, Emmanuel and Vampertzis, Themistoklis and Wadia, Farokh and Rad, Darius Rares and Barmpagianni, Christina and Zervos, Ioannis A and Tsiridis, Eleftherios and Galanis, Nikiforos},
title = {Botulinum toxin in fracture management: a scoping review},
journal = {European Journal of Orthopaedic Surgery & Traumatology},
year = {2025},
doi = {10.1007/s00590-025-04295-4}
}
EUVIMED